the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese Korean Chinese

Market Research Report

Customer Relationship Strategies in Medical Device & Diagnostic Industry - Role of CRM and Knowledge Management

Published by HBS Consulting Contact us : +1-860-674-8796
Published 2005/12 Content info 103 pages
Product code HBS35239
Price From  US $ 4163 Order/Price list
US $ 4163 MS Word file by E-mail (Single User License)
US $ 4163 PDF by E-mail (Single User License)
US $ 4213 Hard Copy
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Abstract

Customer Relationship Strategies in Medical Device Industry - Role of CRM and Knowledge Management

"Customer Relationship Strategies in Medical Device Industry - Role of CRM and Knowledge Management" will be of particular value to business development, marketing and top-line corporate personnel in the medical device industry who are seeking to gain competitive advantage through enhanced knowledge and relationship strategies. This Strategy Review describes how medical device companies are using these strategies to better:

  • identify up-sell and cross-sell opportunities
  • identify partnership and collaborative agreements for new product development
  • identify creation of profit from interaction with key opinion leaders and influencers
  • realise increased collaboration with distributors to promote channel efficiencies
  • create more highly trained, motivated and pro-active sales forces
  • apply customer segmentation strategies to positively impact the bottom line and
  • manage employee knowledge to drive innovation

Executive Summary

Healthcare Providers & Medical Technology The healthcare finance crisis globally has important ramifications for medical technology companies. In each member state of the European Union, health services are beginning to commission studies to explore the cost effectiveness of healthcare products. This means that the manufacturer needs to demonstrate a product's safety and clinical efficacy through health technology assessments (HTA) and demonstrate a product's cost-effectiveness within this process. Similarly, product selection - previously the responsibility of clinicians - is becoming the responsibility of administrative personnel who manage hospital purchasing agreements, and who tend to ignore features and benefits in favour of securing lower prices or meeting practice guidelines and protocols. As a result, manufacturers are expected to broaden their marketing style from an emphasis on the clinical features and benefits of products to the fulfilment of the organisational needs of national healthcare delivery systems. Finally, as private expenditures increasingly make up the difference between the need for high-technology products and reductions in healthcare spending, manufacturers will need to market affordable products to both the public and private sectors.

Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.